Butler-Laporte, Guillaume http://orcid.org/0000-0001-5388-0396
Farjoun, Joseph
Nakanishi, Tomoko http://orcid.org/0000-0001-9510-5646
Lu, Tianyuan http://orcid.org/0000-0002-5664-5698
Abner, Erik http://orcid.org/0000-0002-6529-3161
Chen, Yiheng
Hultström, Michael http://orcid.org/0000-0003-4675-1099
Metspalu, Andres http://orcid.org/0000-0002-3718-796X
Milani, Lili http://orcid.org/0000-0002-5323-3102
Mägi, Reedik http://orcid.org/0000-0002-2964-6011
Nelis, Mari
Hudjashov, Georgi
,
Yoshiji, Satoshi
Ilboudo, Yann
Liang, Kevin Y. H.
Su, Chen-Yang http://orcid.org/0000-0001-6071-4660
Willet, Julian D. S. http://orcid.org/0000-0002-8103-0329
Esko, Tõnu
Zhou, Sirui
Forgetta, Vincenzo
Taliun, Daniel
Richards, J. Brent http://orcid.org/0000-0002-3746-9086
Article History
Received: 9 June 2023
Accepted: 20 October 2023
First Online: 3 November 2023
Competing interests
: The authors declare the following competing interests: JBR’s institution has received investigator-initiated grant funding from Eli Lilly, GlaxoSmithKline and Biogen for projects unrelated to this research. He is the CEO of 5 Prime Sciences Inc (). J.F., T.L., and V.F. are employees of 5 Prime Sciences Inc. T.N. has received a speaking fee from Boehringer Ingelheim for talks unrelated to this research. The other authors declare no competing interests.
: The UKB was approved by the Northwest Multi-centre Research Ethics (approval number: 11/NW/0382). The activities of the Estonian Biobank are regulated by the Human Genes Research Act, which was adopted in 2000 specifically for the operations of Estonian Biobank. Individual level data analysis in Estonian Biobank was carried out under ethical approval 1.1-12/624 from the Estonian Committee on Bioethics and Human Research (Estonian Ministry of Social Affairs), using data according to release application 6-7/GI/8592 from the Estonian Biobank. Informed consent was obtained from all participants.